BridgeBio Pharma
Price & Volume
Stats
See moreOpen | $66.79 |
Previous Close | $67.61 |
Day Range | $65.48-$68.45 |
52W Range | $28.32-$84.94 |
Market Cap | $12.7B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $502M |
Revenue Growth (YoY) | 2,521.2% |
Gross Profit (12 Mos) | $481.1M |
Diluted EPS | -$4.21 |
News
See moreYahoo Finance • 3 days ago
BridgeBio outlines transition to cash generation by 2028 with $600M profit target, driven by pipeline advances and Attruby growth
Yahoo Finance • 3 days ago
BridgeBio Pharma GAAP EPS of -$1.00 misses by $0.33, revenue of $154.2M beats by $5.13M
Yahoo Finance • 10 days ago
BoFA Notes BridgeBio Pharma, Inc. (BBIO)’s Upcoming Q4 Earnings May Have Limited Market Impact
Yahoo Finance • 10 days ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
About
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 725 |
